Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study of metastasis

09.07.2004


Metastasis of cancer may cause as many, if not more, deaths than cancer itself. Amongst other reasons, this is because it is very difficult to know where the new tumour is going to develop. Moreover, the mechanisms of metastasis are still not well understood, although a lot of research into it is taking place and advances are being made. Dominion Pharmakine is a company located at the Bizkaia Technological Park where they are studying metastasis.




At times, a cell in our body may suffer a mutation and starts to multiply in an uncontrolled manner. All the cells thus formed result in a tumour which interferes in the form and functions of the tissue of which it is part. Moreover, the tumour provokes the creation of new blood vessels, which assures a good food supply.

If the tumour limits itself to growing, it is said to be a benign tumour and, in most cases, does not require treatment. But, if malignant, it must be treated. If not extirpated, pharmaceutical drugs have to be used to combat the tumour. But the tumour usually has a number of defence mechanisms. One of these is a proteic layer difficult to penetrate by some of these drugs. Dominion Pharmakine is studying which these area and also the suitability of the molecular targets used by the new drugs for bonding to the pathological cells, i.e. they are trying to identify the molecule that best offers the possibility of penetration of the unhealthy cell.


But unfortunately, malign tumours, apart from growing, may spread throughout the body, i.e. they may produce a metastasis. Some of the cells separate from the tumour and are carried to other parts of the body through the blood system, via the newly-formed vessels. Once in the blood system, it is distributed through the whole body until they attach themselves to some new tissue and initiate a new tumour.

Metastasis initiates as a consequence of two changes in the genetic expression and protein synthesis that occur in the initial tumour. Dominion Pharmakine is also investigating the relationship between this genetic expression and metastasis. From this information, two objectives are sought: on the one hand, predicting the evolution of the tumour using the genetic expression arising and, on the other, designing new specific drugs based on this expression.

The Dominion Pharmakine company was formed as a spin off of the Faculty of Medicine at the University of the Basque Country.

Eneko Imaz | Basque Research
Further information:
http://www.pharmakine.com
http://www.elhuyar.com

More articles from Life Sciences:

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>